About VBI Vaccines
VBI Vaccines is a publicly listed company based in Cambridge (United States) founded in 2001. VBI Vaccines is engaged in developing vaccines and immunotherapeutics. It operates on a Direct-to-Consumer (D2C) and B2B2C model. VBI Vaccines has raised $65.07 million across 23 funding rounds from investors including Blackstone, National Research Council Canada and RTW Investments. VBI Vaccines has completed 2 acquisitions, including Epixis and SciVac Therapeutics. Its website vbivaccines.com draws about 11 thousand monthly visits. VBI Vaccines offers products and services including PreHevbrio and VBI-2601. Its focus areas include Biotechnology and Vaccines. Its legal entity is VBI Vaccines Inc. Its competitors include Moderna, Adaptive Biotechnologies and Novavax; 2 of its 3 listed competitors have raised funding.
Company details
VBI Vaccines is focused on the development of vaccine and immunotherapeutic candidates aimed at addressing significant unmet needs in infectious diseases and oncology. The company operates in the healthcare sector, targeting conditions such as hepatitis B and various cancers with innovative solutions. Their pipeline includes both prophylactic vaccines to prevent diseases and therapeutic immunotherapeutics to treat existing conditions by harnessing the immune system. Operations are supported by facilities in the United States, Canada, and Israel, covering research, development, and manufacturing activities.
- Headquarters Cambridge, United States
- Stage Public
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website vbivaccines.com
- Social LinkedIn X Facebook YouTube
- Legal Name Vbi Vaccines Inc.
- Total Equity Funding$65.07M (USD)
in 23 rounds
- InvestorsBlackstone
& 7 more
- Investments & AcquisitionsEpixis
& 1 more
Products & Services of VBI Vaccines
VBI Vaccines offers a comprehensive portfolio of products and services, including PreHevbrio and VBI-2601.
A hepatitis B vaccine is developed for prevention.
An HBV immunotherapeutic is designed for treatment purposes.
Apps and channels of VBI Vaccines
its YouTube channel VBI Vaccines Inc. has 235 subscribers and 16 videos.
Videos from VBI Vaccines
The most watched videos on VBI Vaccines's YouTube channel, VBI Vaccines Inc. (235 subscribers). Click a video to play it here.
More on VBI Vaccines Inc..
Funding Insights of VBI Vaccines
VBI Vaccines has successfully raised a total of $65.07M across 23 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $65.07M
- Total Rounds 23
- First Round $35.7M
(Jan 2007)
- Investors Count 8
Latest 10 of 23 funding rounds of VBI Vaccines with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2020 | Grant | – | – | ||
| May 2020 | $4.7M | Post-IPO | – | – | – |
| Apr 2020 | $1.06M | Post-IPO | – | – | – |
| Dec 2018 | $7M | Post-IPO | – | – | – |
| Dec 2016 | $10.6M | Post-IPO | – | – | – |
| Dec 2016 | $13M | Debt – Conventional | – | – | |
| Jul 2016 | $13.61M | Post-IPO | – | – | |
| Sep 2015 | $265,000 | Grant | – | – | |
| Aug 2015 | $6.29M | Series A | – | – | |
| Jul 2014 | $16.25M | Series A | – | – | – |
8 investors in total: 8 institutional.
Investors in VBI Vaccines
VBI Vaccines has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Blackstone, National Research Council Canada and RTW Investments.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Health-tech companies are targeted for venture capital investments. | 1999 | perceptivelife.com | New York, United States | |
Venture capital firm focused on life science companies | 1986 | archventure.com | Chicago, United States | |
Life Sciences focused VC firm investing in the US | 2010 | rtwfunds.com | New York, United States | |
Venture capital fund backed incubator focused on the healthcare startups | 5amventures.com | San Francisco, United States | ||
Diversified investment management is provided across multiple asset classes. | 1985 | blackstone.com | New York, United States | |
Canadian space agency focused on social and economic benefits | 1989 | asc-csa.gc.ca | Longueuil, Canada | |
Molecular diagnostic products for prostate cancer assessment are provided. | 1991 | opko.com | Miami, United States | |
Scientific and technological research is conducted for Canada's benefit. | 1916 | nrc.canada.ca | Ottawa, Canada |
Investor details for VBI Vaccines
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of VBI Vaccines
34 people are tracked at VBI Vaccines (7 in leadership, 18 in board & advisors, 9 in team).
| Name | Role | Group |
|---|---|---|
Jeff Baxter | President & CEO | Leadership |
Avi Mazaltov | Global Head of Manufacturing and SciVac General Manager | Leadership |
John Dillman | Chief Commercial Officer | Leadership |
Catalina Soare | VP Preclinical Translational Development | Leadership |
Susan Brown | Director Human Resources | Leadership |
Dr. Francisco Diaz-Mitoma | Chief Medical Officer | Leadership |
Francisco Diaz-Mitoma | Chief Medical Officer | Leadership |
Denis R. Burger | Advisor | Board & advisors |
Joanne Cordeiro | Director | Board & advisors |
Pierre Van Damme | Advisor | Board & advisors |
Blaine McKee | Director | Board & advisors |
Damian Braga | Director | Board & advisors |
Steven Gillis | Chair, Board of Directors | Board & advisors |
Adam Finn | Advisor | Board & advisors |
Peter A. Patriarca | Advisor | Board & advisors |
Allen Waziri | Advisor | Board & advisors |
Nadia G. Tornieporth | Advisor | Board & advisors |
Stanley Plotkin | Advisor | Board & advisors |
Bruce Smith | Advisor | Board & advisors |
Stefan Thoelen | Advisor | Board & advisors |
14 more people are available in the full profile.
Complete people profiles for VBI Vaccines
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by VBI Vaccines
VBI Vaccines has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Epixis and SciVac Therapeutics.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Hepatitis B vaccine development was focused on by SciVac Therapeutics. | scivactherapeutics.com | Rehovot, Israel | 2005 | Oct 2015 | •••• | |
French biotech developing e-VLP (virus like particles) immunotherapies for Hep-C. Acquired by VBI Vaccines in 2011 | epixis.com | Paris, France | 2003 | Sep 2011 | •••• |
Complete acquisition details for VBI Vaccines
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of VBI Vaccines
6 dated milestones of VBI Vaccines across 19 years, from founding to its latest funding, stage changes and deals.
- Founded VBI Vaccines is founded.
- Funding First funding round of $35.7M.
- Acquisition Acquires Epixis.
- Acquisition Acquires SciVac Therapeutics.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Grant,.
Competitors of VBI Vaccines
VBI Vaccines has 3 listed competitors in our database, 2 of them funded. They include Moderna, Adaptive Biotechnologies and Novavax.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| modernatx.com | 2010 | Cambridge, United States | $2.78B | 1,312 | mRNA-based therapeutics for diseases including cancer and infections are developed. | |
| adaptivebiotech.com | 2009 | Seattle, United States | $419.15M | 609 | Clinical diagnostics and drug discovery for immune diseases are provided. | |
| novavax.com | 1987 | Gaithersburg, United States | 184 | Novel vaccines are developed using nanoparticle and matrix adjuvant technology. |
Detailed competitors of VBI Vaccines
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of VBI Vaccines
The website of VBI Vaccines (vbivaccines.com) receives about 11.4K visits a month and ranks #3,481,567 among all websites worldwide, #4,521 in Biotechnology and Pharmaceuticals.
- Monthly visits11.4K
▲ 101.9% vs previous month
- Unique visitors2.3K
per month
- Global rank#3,481,567
among all websites
- Category rank#4,521
Health · Biotechnology and Pharmaceuticals
- Bounce rate38%
- Pages per visit1.7
- Average visit30 sec
- DevicesDesktop 30% · Mobile 70%
Websites whose visitors overlap most with VBI Vaccines. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| genocea.com | 100% | View details | |||
| medicago.com | 98% | View details | |||
nanobio.com | nanobio.com | 98% | – | ||
| aeras.org | 61% | View details | |||
vactruth.com | vactruth.com | 61% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 9 similar websites and full traffic analytics for VBI Vaccines
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 9 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Immunology & Cancer Therapeutics
3 companies that operate in the same segment as VBI Vaccines (Immunology & Cancer Therapeutics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Targeted and immune-oncology drugs for cancer treatment are developed. | 2010 | Cambridge, Massachusetts, United States | USD 172 M | |||
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Vbi Vaccines
Complete news archive for VBI Vaccines
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about VBI Vaccines
VBI Vaccines was founded in 2001 and raised its 1st funding round 6 years after it was founded.
VBI Vaccines is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
VBI Vaccines is a funded company, having raised a total of $65.07M across 23 funding rounds to date. The company's 1st funding round was a Series A of $16.25M, raised on Jan 2007.
VBI Vaccines is focused on the development of vaccine and immunotherapeutic candidates aimed at addressing significant unmet needs in infectious diseases and oncology. The company operates in the healthcare sector, targeting conditions such as hepatitis B and various cancers with innovative solutions. Their pipeline includes both prophylactic vaccines to prevent diseases and therapeutic immunotherapeutics to treat existing conditions by harnessing the immune system. Operations are supported by facilities in the United States, Canada, and Israel, covering research, development, and manufacturing activities.
VBI Vaccines's top competitors include Moderna, Adaptive Biotechnologies and Novavax.
VBI Vaccines offers PreHevbrio and VBI-2601.
VBI Vaccines has made 2 acquisitions, including Epixis, and SciVac Therapeutics.
VBI Vaccines has 8 investors. Key investors include Blackstone, National Research Council Canada, RTW Investments, Opko Health, and Arch Venture Partners.
VBI Vaccines operates through Vbi Vaccines Inc..